Kuhlmann, Christoph R W <br/><br/>
Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains.  [electronic resource] 

 -  Neuropharmacology  Sep 2006 
 - 907-13 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2006.06.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Antioxidants--pharmacology<br/>Astrocytes--drug effects<br/>Biological Transport--drug effects<br/>Blood-Brain Barrier--drug effects<br/>Capillary Permeability--drug effects<br/>Cattle<br/>Cells, Cultured<br/>Coculture Techniques--methods<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Electric Impedance<br/>Endothelial Cells--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Fatty Acids, Monounsaturated--pharmacology<br/>Fluvastatin<br/>Indoles--pharmacology<br/>Mice<br/>Microscopy, Confocal--methods<br/>Models, Animal<br/>Myosin Light Chains--metabolism<br/>Nitric Oxide--metabolism<br/>Rats<br/>omega-N-Methylarginine--pharmacology